Evidence map›Paper›PMID 25287718›Full record

ArticleProtein science : a publication of the Protein Society2015

Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.

Tracy R Clinton, Matthew T Weinstock, Michael T Jacobsen, Nicolas Szabo-Fresnais, Maya J Pandya, Frank G Whitby, Andrew S Herbert, Laura I Prugar, Rena McKinnon, Christopher P Hill and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Protein Science best paper awards to Tracy Clinton and Michael Thompson.Protein science : a publication of the Protein Society · 2016
    Article
  14. Article
  15. Protein engineering in the 21st century.Protein science : a publication of the Protein Society · 2015
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Tracy R ClintonDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, 84112-5650.
Matthew T Weinstock
Michael T Jacobsen
Nicolas Szabo-Fresnais
Maya J Pandya
Frank G Whitby
Andrew S Herbert
Laura I Prugar
Rena McKinnon
Christopher P Hill
Brett D Welch
John M Dye
Debra M Eckert
Michael S Kay
University of Utah · USUnited States Army Medical Research Institute of Infectious Diseases · USNavigen (United States) · US

Funding

X-ray Cryst. CoreP50GM082545 · NIGMS · UNIVERSITY OF UTAH · PI SUNDQUIST, WESLEY I. · 2007 to 2018
$51.1M
Protease-resistant D-peptide Inhibitors of Ebola Virus EntryR44AI102347 · NIAID · NAVIGEN, INC. · PI WELCH, BRETT D · 2015 to 2017
$2.9M
Protease-resistant D-peptide Inhibitors of Ebola Virus EntryR43AI102347 · NIAID · NAVIGEN, INC. · PI WELCH, BRETT D · 2012 to 2013
$600k
NIAID NIH HHS AI102347NIAID NIH HHS R43 AI102347NIAID NIH HHS R44 AI102347NIGMS NIH HHS GM82545NIGMS NIH HHS P50 GM082545
6 · The paper itself

Abstract

Ebolaviruses are highly lethal filoviruses that cause hemorrhagic fever in humans and nonhuman primates. With no approved treatments or preventatives, the development of an anti-ebolavirus therapy to protect against natural infections and potential weaponization is an urgent global health need. Here, we describe the design, biophysical characterization, and validation of peptide mimics of the ebolavirus N-trimer, a highly conserved region of the GP2 fusion protein, to be used as targets to develop broad-spectrum inhibitors of ebolavirus entry. The N-trimer region of GP2 is 90% identical across all ebolavirus species and forms a critical part of the prehairpin intermediate that is exposed during viral entry. Specifically, we fused designed coiled coils to the N-trimer to present it as a soluble trimeric coiled coil as it appears during membrane fusion. Circular dichroism, sedimentation equilibrium, and X-ray crystallography analyses reveal the helical, trimeric structure of the designed N-trimer mimic targets. Surface plasmon resonance studies validate that the N-trimer mimic binds its native ligand, the C-peptide region of GP2. The longest N-trimer mimic also inhibits virus entry, thereby confirming binding of the C-peptide region during viral entry and the presence of a vulnerable prehairpin intermediate. Using phage display as a model system, we validate the suitability of the N-trimer mimics as drug screening targets. Finally, we describe the foundational work to use the N-trimer mimics as targets in mirror-image phage display, which will be used to identify D-peptide inhibitors of ebolavirus entry.

Indexed as

Amino Acid SequenceDrug Delivery SystemsEbolavirusModels, MolecularMolecular Sequence DataProtein ConformationSequence AlignmentViral Envelope Proteinsenvelope glycoprotein, Ebola virusViral Envelope Proteinsdesigned coiled coilebolavirusebolavirus GP2filovirus entrymirror-image phage displayN-trimerphage displayprehairpin intermediate

Identifiers

PMID25287718
PMCPMC4380977
OpenAlexW2121156579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.